Preliminary results for a phase II study of sintilimab combined with chemotherapy followed by concurrent chemoradiotherapy as conversion therapy for unresectable locally advanced esophageal squamous cell carcinoma (NICE-CS trial) (ESMO Asia 2026) - Oct 1, 2026 - Abstract #1059P; Pres time: Dec 4, 2026; 05:15 PM - 06:15 PM; Location: Poster area (Exhibition); No abstract available
Metastases • P2 data • Esophageal Squamous Cell Carcinoma • Oncology • Squamous Cell Carcinoma
|
|
Yuxi Yi; Jun Liu; Yipengchen Yin; Zhigang Li; Jun Liu
|